Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cody J Peer

Showing results (91-100 of 140) with videos related to

Pageof 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2014
An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancerMichael S Gordon, Francisco Robert, Daniela Matei, et al.
Cancer|November 14, 2015
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancerAnne M Noonan, Kristen P Bunch, Jin-Qiu Chen, et al.
Cell Death & Disease|April 28, 2022
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumorsAshlyn Parkhurst, Sabrina Z Wang, Tyler R Findlay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II StudyMark N Polizzotto, Thomas S Uldrick, Kathleen M Wyvill, et al.
Science Translational Medicine|December 22, 2021
Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibioticsJay-Hyun Jo, Catriona P Harkins, Nicole H Schwardt, et al.
Clinical Colorectal Cancer|April 12, 2015
A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal CancerKhanh Do, Liang Cao, Zhigang Kang, et al.
Translational Lung Cancer Research|August 2, 2019
A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancerTakefumi Komiya, Regan M Memmott, Gideon M Blumenthal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2015
Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma CellsMahadev Rao, Scott M Atay, Vivek Shukla, et al.
The Oncologist|March 26, 2017
A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi SarcomaThomas S Uldrick, Priscila H Gonçalves, Kathleen M Wyvill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's CancerJung-Min Lee, Cody J Peer, Minshu Yu, et al.
Pageof 14

Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2014
An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancerMichael S Gordon, Francisco Robert, Daniela Matei, et al.
Cancer|November 14, 2015
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancerAnne M Noonan, Kristen P Bunch, Jin-Qiu Chen, et al.
Cell Death & Disease|April 28, 2022
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumorsAshlyn Parkhurst, Sabrina Z Wang, Tyler R Findlay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II StudyMark N Polizzotto, Thomas S Uldrick, Kathleen M Wyvill, et al.
Science Translational Medicine|December 22, 2021
Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibioticsJay-Hyun Jo, Catriona P Harkins, Nicole H Schwardt, et al.
Clinical Colorectal Cancer|April 12, 2015
A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal CancerKhanh Do, Liang Cao, Zhigang Kang, et al.
Translational Lung Cancer Research|August 2, 2019
A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancerTakefumi Komiya, Regan M Memmott, Gideon M Blumenthal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2015
Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma CellsMahadev Rao, Scott M Atay, Vivek Shukla, et al.
The Oncologist|March 26, 2017
A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi SarcomaThomas S Uldrick, Priscila H Gonçalves, Kathleen M Wyvill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's CancerJung-Min Lee, Cody J Peer, Minshu Yu, et al.
Pageof 14